David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.36% |
| 2 | Technology | 13.15% |
| 3 | Financials | 9.51% |
| 4 | Healthcare | 7.52% |
| 5 | Consumer Discretionary | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CCAI
3151
DELISTED
Cascadia Acquisition Corp. Class A Common Stock
CCAI
| $1.43M | ﹤0.01% |
144,949
| – | – |
|
|
LOVE
3152
LoveSac
LOVE
$235M
| $1.42M | ﹤0.01% |
69,855
+55,388
| +383% | +$1.7M |
|
|
EGRX
3153
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.42M | ﹤0.01% |
53,894
-43,970
| -45% | -$1.61M |
|
|
CAUD
3154
DELISTED
Collective Audience, Inc.. Common Stock
CAUD
| $1.42M | ﹤0.01% |
141,914
| – | – |
|
3155
Arcutis Biotherapeutics
ARQT
$3.13B
| $1.42M | ﹤0.01% |
+74,376
| New | +$1.69M |
|
|
BLEU
3156
DELISTED
bleuacacia ltd Class A Ordinary Shares
BLEU
| $1.42M | ﹤0.01% |
144,148
+430
| +0.3% | +$4.22K |
|
3157
Personalis
PSNL
$1.79B
| $1.42M | ﹤0.01% |
477,887
+136,646
| +40% | +$521K |
|
3158
Rockwell Automation
ROK
$48.1B
| $1.42M | ﹤0.01% |
6,595
-8,808
| -57% | -$2.05M |
|
3159
Comscore
SCOR
$79.4M
| $1.42M | ﹤0.01% |
42,994
-27
| -0.1% | -$1.11K |
|
3160
PUT
Blink Charging
BLNK
$83.5M
| $1.42M | ﹤0.01% |
80,000
| – | – |
|
3161
Bank of N.T. Butterfield & Son
NTB
$2.33B
| $1.42M | ﹤0.01% |
43,629
-44,442
| -50% | -$1.48M |
|
|
TSE
3162
PUT
DELISTED
Trinseo
TSE
| $1.42M | ﹤0.01% |
+77,300
| New | +$2.42M |
|
3163
SFL Corp
SFL
$1.64B
| $1.42M | ﹤0.01% |
155,319
+83,775
| +117% | +$849K |
|
3164
ORIX
IX
$42.3B
| $1.41M | ﹤0.01% |
100,050
+4,560
| +5% | +$74.5K |
|
3165
O-I Glass
OI
$1.11B
| $1.41M | ﹤0.01% |
109,192
-137,446
| -56% | -$1.86M |
|
|
PTVE
3166
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $1.41M | ﹤0.01% |
161,796
+20,228
| +14% | +$210K |
|
|
NUVA
3167
DELISTED
NuVasive, Inc.
NUVA
| $1.41M | ﹤0.01% |
+32,223
| New | +$1.56M |
|
|
VISN
3168
Vistance Networks Inc
VISN
$2.68B
| $1.41M | ﹤0.01% |
153,118
-210,445
| -58% | -$2.02M |
|
3169
Funko
FNKO
$377M
| $1.41M | ﹤0.01% |
69,630
-212,486
| -75% | -$4.87M |
|
3170
CALL
PBF Energy
PBF
$8.13B
| $1.41M | ﹤0.01% |
40,000
+30,400
| +317% | +$963K |
|
|
ONEM
3171
DELISTED
1Life Healthcare
ONEM
| $1.41M | ﹤0.01% |
81,946
-357,554
| -81% | -$5.61M |
|
3172
Bristow Group
VTOL
$1.36B
| $1.4M | ﹤0.01% |
59,723
-41,397
| -41% | -$1.08M |
|
3173
CALL
AeroVironment
AVAV
$7.74B
| $1.4M | ﹤0.01% |
+16,800
| New | +$1.5M |
|
|
SRCL
3174
DELISTED
Stericycle Inc
SRCL
| $1.4M | ﹤0.01% |
33,167
+19,992
| +152% | +$962K |
|
3175
Byline Bancorp
BY
$1.73B
| $1.4M | ﹤0.01% |
68,911
+28,342
| +70% | +$649K |
|
Similar funds
David Shaw's Q3 2022 Portfolio in Review
As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
David Shaw withdrew a net $7.97B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in Prologis worth $66.1M.
- David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
- David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- David Shaw opened 545 new positions and closed 678 in Q3 2022.
- David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.